Open Treatments is a software platform that allows patients, families, and caregivers to develop a streamlined treatment plan for rare diseases. Open Treatments provides a roadmap of the drug development pathway, which covers every point of this process, from planning to clinical trials. Open Treatments also offers access to expert advice and research infrastructure to help educate individuals about gene therapy and drug development.
Open Treatment is currently partnered with the following patient centered organizations: CUREGPX4, IDefine, CureCMD, INADCure.